Every time Tanya publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...

Botox is a prescription drug used to reduce wrinkles and treat medical conditions such as overactive bladder and chronic migraine. The drug comes as a powder and is diluted with saline before it’s ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

AbbVie’s Allergan Aesthetics unit earlier this year had its first-ever open casting call as it looked for a new Botox campaign that would comprise real people using its product as a cosmetic and boy, ...

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...

NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...